Background: Estimating the future risk of cardiovascular diseases (CVDs) and conducting primary prevention interventions in the high-risk groups are effective strategies. Objectives: This study was conducted to evaluate the prevalence of CVD risk factors and the results of CVD risk assessment in Kerman in 2017. Methods: A descriptive cross-sectional study was conducted among 450 middle-aged participants referring to health care centers using the multistage random sampling method. The risk prediction chart developed by the WHO and International Society of Hypertension was used for risk assessment. We used middle-aged population surveillance forms to extract the risk factors of CVDs. The prevalence of different risk factors was reported. Besi...
Aims: Cardiovascular Diseases (CVDs) are the main causes of death and have the first place among oth...
BackgroundDyslipidemia (DL) is an important risk factor of coronary artery disease (CAD). We evaluat...
Cardiovascular disease is becoming the leading cause of mortality and morbidity worldwide, and devel...
Background: Cardiovascular diseases (CVDs) are the leading cause of death in Iran. The present study...
Background: The risk of disease with 1 risk factor is increased by the presence of additional risk f...
Background: Data on incidence of coronary heart disease (CHD) is scarce in the Middle East and littl...
Background The prevalence of cardiovascular disease (CVD) is rapidly increasing in ...
Introduction: Among the chronic diseases, cardiovascular disease is the most important and most comm...
Abstract Background and Aims: Cardiovascular diseases (CADs) are the most important causes of mortal...
BACKGROUND AND OBJECTIVE: Risk assessment is one of the most important strategies in estimating the ...
Introduction : Studying the prevalence of cardiovascular risk factors in low socioeconomic groups is...
IntroductionCardiovascular disease is a major health problem in Saudi Arabia, estimates on the preva...
Background: Regarding the social changes and epidemiological transition from communicable to non-co...
Background and aims Cardiovascular disease (CVD) is known as a health threat. In Iran CVD is the f...
Background and aim: Cardiovascular diseases are a problem in low- and middle-income countries, such ...
Aims: Cardiovascular Diseases (CVDs) are the main causes of death and have the first place among oth...
BackgroundDyslipidemia (DL) is an important risk factor of coronary artery disease (CAD). We evaluat...
Cardiovascular disease is becoming the leading cause of mortality and morbidity worldwide, and devel...
Background: Cardiovascular diseases (CVDs) are the leading cause of death in Iran. The present study...
Background: The risk of disease with 1 risk factor is increased by the presence of additional risk f...
Background: Data on incidence of coronary heart disease (CHD) is scarce in the Middle East and littl...
Background The prevalence of cardiovascular disease (CVD) is rapidly increasing in ...
Introduction: Among the chronic diseases, cardiovascular disease is the most important and most comm...
Abstract Background and Aims: Cardiovascular diseases (CADs) are the most important causes of mortal...
BACKGROUND AND OBJECTIVE: Risk assessment is one of the most important strategies in estimating the ...
Introduction : Studying the prevalence of cardiovascular risk factors in low socioeconomic groups is...
IntroductionCardiovascular disease is a major health problem in Saudi Arabia, estimates on the preva...
Background: Regarding the social changes and epidemiological transition from communicable to non-co...
Background and aims Cardiovascular disease (CVD) is known as a health threat. In Iran CVD is the f...
Background and aim: Cardiovascular diseases are a problem in low- and middle-income countries, such ...
Aims: Cardiovascular Diseases (CVDs) are the main causes of death and have the first place among oth...
BackgroundDyslipidemia (DL) is an important risk factor of coronary artery disease (CAD). We evaluat...
Cardiovascular disease is becoming the leading cause of mortality and morbidity worldwide, and devel...